Jia R, Wang H. How Could In Vitro Antiviral Activity Be Applied to Optimize the Dosing Regimens of Candidates for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)? Clin Infect Dis 2020 Nov 27. pii: 6007043. doi: 10.1093/cid/ciaa1325.
PMID: 33244589